Overview

  • Product name
    Anti-RBM35A + RBM35B antibody [23A7.C9]
  • Description
    Mouse monoclonal [23A7.C9] to RBM35A + RBM35B
  • Specificity
    ab106555 recognises both Mouse RBM35A and RBM35B.
  • Tested applications
    Suitable for: WBmore details
  • Species reactivity
    Reacts with: Mouse
    Predicted to work with: Rat, Horse, Cow, Dog, Human, Pig, Chimpanzee, Opossum
  • Immunogen

    Recombinant full length Mouse RBM35A with a proprietary tag (NP_918944.2).

  • Positive control
    • RBM35A or RBM35B transfected 293T cell extracts

Properties

  • Form
    Liquid
  • Storage instructions
    Shipped at 4°C. Upon delivery aliquot. Store at -20°C or -80°C. Avoid freeze / thaw cycle.
  • Storage buffer
    pH: 7.20
    Preservative: 0.01% Sodium azide
    Constituents: 0.42% Potassium phosphate, 0.88% Sodium chloride
  • Concentration information loading...
  • Purity
    Protein A purified
  • Purification notes
    ab106555 was purified from tissue culture supernatant by Protein A chromatography followed by extensive dialysis against the buffer stated. The antibody is sterile filtered.
  • Clonality
    Monoclonal
  • Clone number
    23A7.C9
  • Isotype
    IgG1

Applications

Our Abpromise guarantee covers the use of ab106555 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB 1/1000. Predicted molecular weight: 76, 77 kDa.

Target

Images

  • All lanes : Anti-RBM35A + RBM35B antibody [23A7.C9] (ab106555) at 1/1000 dilution

    Lane 1 : GFP transfected 293T cell extract
    Lane 2 : RBM35A transfected 293T cell extract
    Lane 3 : RBM35B transfected 293T cell extract

    Lysates/proteins at 5 µg per lane.

    Secondary
    anti-mouse ECL antibody at 1/10000 dilution
    Developed using the ECL technique

    Predicted band size : 76, 77 kDa

References

This product has been referenced in:
  • Warzecha CC  et al. An ESRP-regulated splicing programme is abrogated during the epithelial-mesenchymal transition. EMBO J 29:3286-300 (2010). Read more (PubMed: 20711167) »

See 1 Publication for this product

Customer reviews and Q&As

There are currently no Customer reviews or Questions for ab106555.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up